Oral Oresentation 3

2:36 PM - 2:42 PM JST(5:36 AM - 5:42 AM UTC)

[O03-07] Real-world experience of switching from intravenous to subcutaneous vedolizumab in Korean patients with inflammatory bowel disease

*Yu Kyung Jun^1,2, Yonghoon Choi¹, Cheol Min Shin^1,2, Young Soo Park¹, Nayoung Kim^1,2, Dong Ho Lee^1,2, Sung Wook Hwang³, Hyuk Yoon^1,2 (1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, 2. Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea, 3. Department of Gastroenterology and Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.